Cavernous angioma epidemiology and demographics

Revision as of 19:45, 3 December 2012 by Charmaine Patel (talk | contribs)
Jump to navigation Jump to search

Cavernous angioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cavernous angioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

MRA

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous angioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous angioma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous angioma epidemiology and demographics

CDC on Cavernous angioma epidemiology and demographics

Cavernous angioma epidemiology and demographics in the news

Blogs on Cavernous angioma epidemiology and demographics

Directions to Hospitals Treating Cavernous angioma

Risk calculators and risk factors for Cavernous angioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The incidence in the general population is between 0.1–0.5%, and clinical symptoms typically appear between 30 to 50 years of age. Once thought to be strictly congenital, these vascular lesions have been found to occur de novo.

Incidence

The incidence in the general population is between 0.1–0.5%.

Prevalence

With the advent of MRI, cavernous malformation are currently the most commonly identified brain vascular malformations.

Multiple Lesions

Multiple lesions are seen in approximately 15-33% of spontaneous cases. A familial form of the disorder exists and is inherited as an autosomal dominant trait with variable expression. Multiple lesions are more common in the familial form, occurring in as many as 73% of patients.

Cavernous malformations also appear to be the most common CNS vascular malformation subtype in patients with mixed lesions. The most common combination include a developmental venous anomaly, which is identified in approximately 10-30% of patients with cavernous angiomas.

Age

Cavernous malformations can occur at any age, but they are most likely to become clinically apparent in patients aged 20-40 years.

References